Therapy Development Team

The Therapy Development Team at Phagenesis Ltd is responsible for advancing the company's innovative device aimed at treating dysphagia through neuroplasticity. This team collaborates on clinical research, manages education programs for healthcare professionals, and oversees the execution of clinical trials to validate the device's effectiveness. They play a crucial role in ensuring that the therapy not only meets regulatory standards but also translates into real-world applications that enhance recovery outcomes for stroke patients.